ArticleCurrent research in behavioral sciences2021
Africa's preparedness towards COVID-19 vaccines: Demand and acceptability challenges.
Article in Current research in behavioral sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 20 citations in OpenAlex.
- Article
- Vaccine inequity: a threat to Africa's recovery from COVID-19.Tropical medicine and health · 2023Review
- COVID-19 vaccine inequity in African low-income countries.Frontiers in public health · 2023Review
- Association between health and safety perceptions of COVID-19 vaccine and its uptake in Ghana.Public health challenges · 2022Article
- Third wave of COVID-19 pandemic in Africa: Challenges and recommendations.Annals of medicine and surgery (2012) · 2022Article
- Children and adolescents in African countries should also be vaccinated for COVID-19.BMJ global health · 2022Article
- Tracer Pharmaceuticals Availability and Distribution Trends Prior to and During the Covid-19 Pandemic: A Comparative Study.Journal of multidisciplinary healthcare · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To date, the response to coronavirus disease (COVID-19) in many African countries has been quick, forward-looking and adjustable in spite of the continent's limited resources. These responses were triggered by the continuous increase in cases and deaths, which have necessitated speedy development of an effective vaccine. It is anticipated that African governments and public health officials will show more transparency, and provide evidence-based strategies to support COVID-19 vaccines and design equitable as well as effective vaccine delivery plans for the populace. To this end, this review analysed Africa's preparedness and response towards COVID-19 vaccines, potential demand, acceptability and distribution challenges related to the management of the virus. The review takes stock of context-specific vaccine preparedness; the demand for vaccine and associated challenges; as well as vaccine accessibility and its distribution. The review offers insightful approaches and strategies by which African countries can maximize benefits from the COVID-19 vaccines to overcome the virus. These include the pursuance of vaccines that may help confer immunity or protection against the virus in the light of contextual circumstances of specific African countries, including sociocultural and economic issues among other factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.